| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |